George Fennell - 13 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for George Fennell
Issuer symbol
IDXX
Transactions as of
13 Feb 2025
Net transactions value
-$59,122
Form type
4
Filing time
18 Feb 2025, 21:42:58 UTC
Previous filing
11 Feb 2025
Next filing
11 Feb 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +51 +0.62% $0.000000 8,227 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +56 +0.68% $0.000000 8,283 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +57 +0.69% $0.000000 8,340 14 Feb 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +140 +1.7% $0.000000 8,480 14 Feb 2025 Direct
transaction IDXX Common Stock Tax liability $59,122 -133 -1.6% $444.53 8,347 14 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +3,415 $0.000000 3,415 13 Feb 2025 Common Stock 3,415 $459.76 Direct F1
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.000000 217 13 Feb 2025 Common Stock 217 $459.76 Direct F2
transaction IDXX Restricted Stock Unit Award $0 +816 $0.000000 816 13 Feb 2025 Common Stock 816 Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -51 -100% $0.000000 0 14 Feb 2025 Common Stock 51 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -56 -50% $0.000000 55 14 Feb 2025 Common Stock 56 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -57 -34% $0.000000 112 14 Feb 2025 Common Stock 57 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -140 -25% $0.000000 417 14 Feb 2025 Common Stock 140 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F3 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F4 Each RSU represents a contingent right to receive one share of Issuer. common stock and vested in four annual installments, beginning on February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2024.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.